We are currently developing applications for the microchip platform with a focus on enhancing the utility and compliance of established preventative and therapeutic agents that require frequent, long-term dosing, delivery via injection or where compliance is critical.
Lead Product: Long-Term Reversible Contraceptive
Our lead product is a microchip-based formulation of a proven hormonal contraceptive designed to provide up to 16 years of reversible birth control. Like all microchip-based applications, the contraceptive can be remotely enabled or disabled by a physician, in the presence of the patient, to meet the evolving long-term family planning needs of women.
In 2012, we received grants from the Bill & Melinda Gates Foundation to develop a microchip-based contraceptive implant that provides 16 years of reversible birth control for women in developing countries who have limited access to routine medical care and modern contraceptive options.
We are developing applications for the microchip platform in osteoporosis, multiple sclerosis, type 2 diabetes, pain management and hormonal diseases.